The Sequester and the FDA | GenomeWeb

While the US Food and Drug Administration has been working to speed up the time it takes for drugs to garner approval, Commissioner Margaret Hamburg says that the sequester may slow those efforts, the Boston Herald reports. Speaking to the Massachusetts Biotechnology Council annual meeting attendees, Hamburg added that she would like Congress to allow FDA to access the user fees it collects to pay for its operating costs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.